Moderate Psoriasis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vtama (tapinarof) is a new treatment for psoriasis that, unlike topical steroids, that can be used anywhere on the body and without time restrictions.

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that new Otezla (apremilast) data, along with findings on the unmet need for patients with plaque...

Psoriasis Market to Exhibit Promising Growth at a CAGR of 5.6% in the United States during the Study Period [2018-2030], States DelveInsight LAS VEGAS, May 11, 2021 /PRNewswire/ -- DelveInsight's " Psoriasis Market" report provides a thorough comprehension of the Psoriasis, historical and forecasted epidemiology, and the Psoriasis market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Psoriasis market report also proffers an analysis of the current Psoriasis treatment algorithm/practice, market drivers, market barriers, and unmet m...

Psoriasis Pipeline Insight 2021 | Latest Advancements in Clinical Trials to Improve Treatment Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping, as many prominent players such as Abbvie, Jannsen, Dermavant Sciences, UCB, Eli Lilly and Company, Boehringer Ingelheim, Pfizer, Arcutis Biotherapeutics, Amgen, Mylan, Clover Biopharmaceuticals, Sienna Biopharmaceuticals, Fresenius Kabi, Celltrion, Bristol Myers Squibb, LEO Pharma, Crescita Therapeutics, GlaxoSmithKline, Coherus BioSciences, Fujifilm Kyowa Kirin Biologics, Zydus Cadilla, S...